Beijing Science Sun Pharmaceutical Co., Ltd.
SZSE:300485.SZ
11.09 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 96.408 | 202.65 | 395.134 | 151.283 | 147.554 | 283.161 | 281.531 | 258.347 | 209.229 | 202.43 | 160.754 | 132.58 | 0 |
| Depreciation & Amortization
| 48.738 | 47.598 | 55.682 | 36.958 | 25.846 | 22.754 | 18.236 | 18.619 | 17.827 | 16.925 | 13.279 | 9.503 | 0 |
| Deferred Income Tax
| 23.909 | 49.266 | 24.914 | -1.973 | -1.687 | -3.237 | -0.389 | 0.136 | 0.049 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 3.447 | 0 | 3.86 | 7.335 | 5.019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 37.788 | 75.696 | 57.496 | 102.138 | 30.953 | -127.115 | -149.891 | -15.973 | -33.992 | -4.924 | 20.458 | 10.103 | 0 |
| Accounts Receivables
| 39.17 | 1.174 | 34.48 | 29.63 | 84.766 | -166.585 | -31.039 | -12.719 | -6.084 | -6.837 | 0 | 0 | 0 |
| Inventory
| -17.97 | 33.962 | 36.523 | 10.588 | 3.364 | -31.332 | -67.117 | -13.956 | -15.131 | -21.355 | 14.413 | -9.178 | 0 |
| Accounts Payables
| -7.321 | -8.707 | -38.421 | 63.893 | -62.826 | 74.039 | -51.346 | 10.566 | -12.827 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 23.909 | 49.266 | 24.914 | -1.973 | 5.648 | -95.783 | -82.774 | -2.018 | -18.861 | 16.431 | 6.045 | 19.281 | 0 |
| Other Non Cash Items
| -161.723 | -268.223 | -325.017 | -28.542 | -37.478 | -32.284 | -41.663 | -48.099 | -23.707 | -0.206 | 2.333 | -0.253 | 0 |
| Operating Cash Flow
| 21.211 | 110.435 | 183.295 | 263.726 | 172.523 | 146.516 | 108.213 | 212.893 | 169.357 | 214.225 | 196.824 | 151.933 | 0 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -52.913 | -43.285 | -45.913 | -117.842 | -111.418 | -198.005 | -141.254 | -147.001 | -31.653 | -9.047 | -19.422 | -80.756 | -27.295 |
| Acquisitions Net
| 0.03 | -4.426 | 15.25 | 0.206 | -32.733 | -59.26 | 0.172 | -105 | -105 | 0 | 0 | 0 | -25.789 |
| Purchases Of Investments
| -52.999 | -205.2 | -97.646 | -253.014 | -130 | -30 | -22 | -105 | 0.014 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 113.847 | 43.862 | 66.79 | 41.973 | 29.204 | 47.458 | 48.54 | 51.737 | 23.715 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -94.229 | 241.44 | -600.949 | -18.71 | 296.554 | -785 | 502.172 | 175.314 | -569.986 | 2 | -19.422 | -80.756 | 0.026 |
| Investing Cash Flow
| -86.264 | 32.391 | -662.469 | -347.387 | 51.606 | -1,024.807 | 387.458 | -129.951 | -682.924 | -7.047 | -19.422 | -80.756 | -53.058 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -54 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | -16.62 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -41.396 | -80.878 | -31.308 | -30.018 | -58.1 | -57.6 | -60 | -43.2 | -54 | -49.5 | -27 | -20 | -42 |
| Other Financing Activities
| 0 | 0.72 | 0 | 15 | 50 | 34.162 | 0 | 0 | 1,138.845 | -0.63 | -0.64 | -2.8 | 105.16 |
| Financing Cash Flow
| -41.396 | -80.158 | -31.308 | -31.638 | -8.1 | -23.438 | -60 | -43.2 | 1,030.845 | -50.13 | -27.64 | -22.8 | 63.16 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0.403 | 2 | -0.507 | -1.288 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -106.046 | 64.667 | -510.989 | -116.587 | 216.029 | -901.728 | 435.67 | 39.743 | 517.278 | 157.049 | 149.762 | 48.377 | 87.163 |
| Cash At End Of Period
| 120.164 | 226.211 | 161.543 | 672.532 | 789.119 | 573.089 | 1,474.818 | 1,039.147 | 999.404 | 482.127 | 325.078 | 175.316 | 126.939 |